| Name |
Administration |
Indication |
| Egrifta® (tesamorelin acetate) |
SAI |
Lipodystrophy in HIV-infected patients |
| Elaprase® (idursu lfase) |
non-SAI |
Hunter Syndrome |
| Eligard® (leuprolide acetate) |
SAI |
Cancer |
| Enbrel® (etanercept) |
SAI |
Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis,
Psoriasis |
| Enoxaparin (generic) |
SAI |
Deep Vein Thrombosis |
| Epogen® (epoetin alfa) |
SAI |
Anemia |
| Epoprostenol sodium (generic) |
non-SAI |
Pulmonary Arterial Hypertension |
| Erbitux® (cetuximab) |
non-SAI |
Cancer |
| Euflexxa® (sodium hyaluronate) |
non-SAI |
Osteoarthritis |
| Exjade® (deferasirox) |
oral |
Blood disorder |
| Extavia® (interferon beta-1b) |
SAI |
Multiple Sclerosis |